Atlas Trials

A Study to Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease

Clinical trial NCT07612150 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07612150
Sponsor
Merry Life Biomedical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2026-08-01
Primary completion
2028-04-30
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.